[go: up one dir, main page]

GB1378296A - Pharmaceutical composition - Google Patents

Pharmaceutical composition

Info

Publication number
GB1378296A
GB1378296A GB5455271A GB5455271A GB1378296A GB 1378296 A GB1378296 A GB 1378296A GB 5455271 A GB5455271 A GB 5455271A GB 5455271 A GB5455271 A GB 5455271A GB 1378296 A GB1378296 A GB 1378296A
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical composition
nov
antidepressant
composition
hydroxytryptophan
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB5455271A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Group PLC
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group PLC filed Critical Beecham Group PLC
Priority to GB5455271A priority Critical patent/GB1378296A/en
Priority to CA156,115A priority patent/CA978088A/en
Priority to ZA728025A priority patent/ZA728025B/en
Priority to FR7241438A priority patent/FR2160947B1/fr
Priority to AU49166/72A priority patent/AU465492B2/en
Priority to NL7215922A priority patent/NL7215922A/xx
Priority to DE2257550A priority patent/DE2257550A1/en
Priority to SE7215299A priority patent/SE394591B/en
Priority to BE791910D priority patent/BE791910A/en
Publication of GB1378296A publication Critical patent/GB1378296A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

1378296 Antidepressant compositions BEECHAM GROUP Ltd 22 Nov 1972 [24 Nov 1971] 54552/71 Heading A5B An antidepressant composition comprises tryptophan, 5-hydroxytryptophan and a carrier.. Both compounds are preferably the L-isomer. The composition may be in the form of tablets, capsules, sachets or multidose packages.
GB5455271A 1971-11-24 1971-11-24 Pharmaceutical composition Expired GB1378296A (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
GB5455271A GB1378296A (en) 1971-11-24 1971-11-24 Pharmaceutical composition
CA156,115A CA978088A (en) 1971-11-24 1972-11-09 Pharmaceutical compositions containing tryptophan and 5-hydroxytryptophan
ZA728025A ZA728025B (en) 1971-11-24 1972-11-13 A pharmaceutical composition containing tryptophan 5-hydroxy trytophan
FR7241438A FR2160947B1 (en) 1971-11-24 1972-11-22
AU49166/72A AU465492B2 (en) 1971-11-24 1972-11-22 Pharmaceutical compositions containing tryptophan and 5-hydroxytryptophan
NL7215922A NL7215922A (en) 1971-11-24 1972-11-23
DE2257550A DE2257550A1 (en) 1971-11-24 1972-11-23 MEDICINAL PREPARATIONS
SE7215299A SE394591B (en) 1971-11-24 1972-11-23 PROCEDURE FOR THE PREPARATION OF A PHARMACEUTICAL PREPARATION APPLICABLE IN THE TREATMENT OF DEPRESSION, CONTAINING INCLUDE
BE791910D BE791910A (en) 1971-11-24 1972-11-24 PHARMACEUTICAL COMPOSITIONS CONTAINING

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB5455271A GB1378296A (en) 1971-11-24 1971-11-24 Pharmaceutical composition

Publications (1)

Publication Number Publication Date
GB1378296A true GB1378296A (en) 1974-12-27

Family

ID=10471388

Family Applications (1)

Application Number Title Priority Date Filing Date
GB5455271A Expired GB1378296A (en) 1971-11-24 1971-11-24 Pharmaceutical composition

Country Status (9)

Country Link
AU (1) AU465492B2 (en)
BE (1) BE791910A (en)
CA (1) CA978088A (en)
DE (1) DE2257550A1 (en)
FR (1) FR2160947B1 (en)
GB (1) GB1378296A (en)
NL (1) NL7215922A (en)
SE (1) SE394591B (en)
ZA (1) ZA728025B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1637185A1 (en) * 2004-09-01 2006-03-22 Ambros Pharma S.r.l. Controlled-release formulations containing tryptophan and/or its metabolites
ITMI20092295A1 (en) * 2009-12-23 2011-06-24 Ambros Pharma S R L PROCEDURE FOR THE PREPARATION OF TABLETS WITH TWO LAYERS INCLUDING 5-HYDROXITRIPTOPHAN AND TRIPTOPHAN

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1637185A1 (en) * 2004-09-01 2006-03-22 Ambros Pharma S.r.l. Controlled-release formulations containing tryptophan and/or its metabolites
US7670619B2 (en) 2004-09-01 2010-03-02 Ambros Pharma S.R.L. Controlled-release formulations containing tryptophan or its metabolites
ITMI20092295A1 (en) * 2009-12-23 2011-06-24 Ambros Pharma S R L PROCEDURE FOR THE PREPARATION OF TABLETS WITH TWO LAYERS INCLUDING 5-HYDROXITRIPTOPHAN AND TRIPTOPHAN
WO2011077406A3 (en) * 2009-12-23 2011-12-01 Ambros Pharma S.R.L. Process for preparing tablets comprising 5- hydroxytryptophan and tryptophan

Also Published As

Publication number Publication date
NL7215922A (en) 1973-05-28
SE394591B (en) 1977-07-04
AU465492B2 (en) 1975-10-02
DE2257550A1 (en) 1973-05-30
ZA728025B (en) 1973-10-31
AU4916672A (en) 1974-05-23
BE791910A (en) 1973-05-24
FR2160947A1 (en) 1973-07-06
CA978088A (en) 1975-11-18
FR2160947B1 (en) 1976-05-21

Similar Documents

Publication Publication Date Title
IL40475A0 (en) Novel tetrazole derivatives,their preparation and pharmaceutical compositions containing them
IL42799A0 (en) Novel carbazole derivatives,their preparation and pharmaceutical compositions containing them
AU473000B2 (en) Novel substituted indole compound, process for the preparation and thereapeutic compositions containing it
ZA723387B (en) New oxadiazole derivatives,processes for the preparation thereof and pharmaceutical composition containing the same
IL36211A0 (en) N(6)-aralkyl-adenosine derivatives,process for the preparation thereof and pharmaceutical compositions containing the same
IL40931A0 (en) Tetrahydrocarbazole derivatives,their manufacture and pharmaceutical compositions containing them
GB1378296A (en) Pharmaceutical composition
IL39851A0 (en) Phenanthridine derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
IL36926A (en) Indole derivatives,their preparation and pharmaceutical compositions containing them
CA968273A (en) PHARMACEUTICAL COMPOSITIONS CONTAINING M-TYROSINE AND .alpha.-HYDRAZINO-3,4-DIHYDROXYPHENYLPROPIONIC ACID
IL36286A0 (en) Erythromycylamine compounds,process for the preparation thereof and pharmaceutical compositions containing the same
IL38593A0 (en) Substituted 2-arylamino-imidazoline-(2)derivatives,their preparation and pharmaceutical compositions containing them
AU441022B2 (en) An improved capsule for containing an article (divisional of 408,028)
IL39337A0 (en) Isoindoline derivatives,processes for their preparation and pharmaceutical compositions containing the same
CA953715A (en) N(6)-(2,5-dimethylbenzyl)-2-chloroadenosine derivatives, process for their preparation and pharmaceutical compositions containing the same
GB1294538A (en) Pharmaceutical compositions
IL41188A0 (en) Phenylalanine derivatives,their preparation and pharmaceutical compositions containing them
IL40639A0 (en) Novel nitrofuran derivatives,processes for their preparation and pharmaceutical compositions containing the same
GB1340528A (en) Psychotropic medicinal composition
IL39204A0 (en) Novel aminophenylketone derivatives,processes for their preparation and pharmaceutical compositions containing the same
GB1338750A (en) Therapeutic composition
IL38870A0 (en) Racemic and optically active 1-(2,5-dichlorophenoxy)-3-tert-butylamino-2-propanol and its salts,their preparation and pharmaceutical compositions containing them
CA945544A (en) 16-METHYLENE-9.beta., 10.alpha.-STEROID COMPOUNDS, PHARMACEUTICAL PREPARATIONS WHICH CONTAIN THE NOVEL COMPOUNDS AS ACTIVE INGREDIENTS, AND METHODS OF PRODUCING THE SAID COMPOUNDSAND PREPARATIONS
AU3542671A (en) New 1, 2, 4-oxadiazole salt, process forthe preparation thereof and pharmaceutical compositions comprising same
GB1358136A (en) Glucocorticoid-like water diuretic and anti-inflammatory compositions

Legal Events

Date Code Title Description
PS Patent sealed
PCNP Patent ceased through non-payment of renewal fee
PCNP Patent ceased through non-payment of renewal fee